Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 147 Results

Title
Intervention Indication Therapeutic Area Year Actions
Setmelanotide for obesity in Bardet-Biedl syndrome and Alstrom syndrome Setmelanotide (RM-493) Hyperphagia , Obesity Endocrine Nutritional and Metabolic Disorders , Gastroenterology , Genetic Disorders 2021 View  |  Download
Sintilimab in combination with pemetrexed and platinum chemotherapy for advanced or metastatic non-small cell lung cancer Carboplatin (Paraplatin) , Pemetrexed (Alimta; pemetrexed ditromethamine dihydrate; pemetrexed ditrometamol; pemetrexed disodium) , Sintilimab (IBI 308; IBI 380; Tyvyt) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2021 View  |  Download
Sparsentan for treating Focal Segmental Glomerulosclerosis Sparsentan (RE-021; PS433540) Focal segmental glomerulosclerosis (FSGS) Nephrology 2021 View  |  Download
Spesolimab for the treatment of acute flares of generalised pustular psoriasis Spesolimab (BI 655130) Generalised pustular psoriasis Dermatology 2021 View  |  Download
Talazoparib in addition to enzalutamide for metastatic castration-resistant prostate cancer Enzalutamide (Xtandi; MDV3100) , Talazoparib (MDV3800; BMN-673; Talzenna; talazoparib tosylate) Prostate cancer Male Reproductive Cancer 2021 View  |  Download
Tirzepatide for treating type 2 diabetes mellitus Tirzepatide (LY3298176) Type 2 diabetes Endocrine Nutritional and Metabolic Disorders 2021 View  |  Download
Tisagenlecleucel for relapsed or refractory follicular lymphoma Tisagenlecleucel-T (Kymriah; CTL019) Follicular lymphoma Haematological Cancer and Lymphomas 2021 View  |  Download
Tisagenlecleucel for treating relapsed or refractory aggressive B-cell non-Hodgkin lymphoma – second line Tisagenlecleucel-T (Kymriah; CTL019) B-cell non-Hodgkin lymphoma Haematological Cancer and Lymphomas 2021 View  |  Download
Tislelizumab for advanced non-small cell lung cancer after platinum based chemotherapy Tislelizumab (BGB-A317; BGBA-317) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2021 View  |  Download
Tislelizumab for oesophageal cancer – second line Tislelizumab (BGB-A317; BGBA-317) Oesophageal cancer Head and Neck Cancer 2021 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications